机构:[1]Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing重点科室诊疗科室神经外科神经外科首都医科大学附属天坛医院[2]China National Clinical Research Center for Neurological Diseases, Beijing[3]Department of Neuropathology, Beijing Neurosurgical Institute, Beijing, China研究所北京市神经外科研究所首都医科大学附属天坛医院
OBJECTIVE: The diagnosis and management for juvenile psammomatoid ossifying fibroma (JPOF) of the skull base are challenging, and clinical data are limited. METHODS: A retrospective review of JPOF was performed, and the clinical characteristics, treatment strategy, and prognosis were analyzed. RESULTS: There were 23 patients pathologically confirmed with JPOF, most with JPOF located in the skull base area (19/23, 82.6%). Of those tumors, 43.5% presented with dura matter breakthrough. Most of the chief complaints were headache (n = 8, 34.8%) and visual impairment (n = 5, 21.7%). Most of the tumors were solid tumors with spherical appearance, frequently accompanied by cysts of various size (n = 14, 60.9%). Craniotomy, mostly via the frontal approach, was the most common approach in the present series, comprising 73.6% (17/23) of all cases. The endoscopic endonasal approach was performed in 6 cases (26.1%). In total, 62.5% of patients (15/23) underwent gross total resection, 8.7% of patients (2/23) underwent subtotal resection, and 26.1% of patients (6/23) underwent partial resection. After a mean follow up of 66.1 +/- 36.1 months (range, 3-124), 3 patients (13.6%) suffered from tumor recurrence with a mean recurrence time of 13 months. CONCLUSIONS: The present series of skull base JPOFs showed that radical surgery combined with skull base reconstruction contributed to overall good prognosis. Further studies are needed to evaluate the long-term outcomes and to characterize its pathologic characteristics.
基金:
Natural Science Foundation of ChinaNational Natural Science Foundation of China [814742370, 81672506]; Special Fund for The Talents of Beijing [2016000021469G212]
第一作者机构:[1]Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing[2]China National Clinical Research Center for Neurological Diseases, Beijing
共同第一作者:
通讯作者:
通讯机构:[1]Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing[2]China National Clinical Research Center for Neurological Diseases, Beijing
推荐引用方式(GB/T 7714):
Wang Ke,Ma Xiu-Jian,Hao Shu-Yu,et al.Skull Base Juvenile Psammomatoid Ossifying Fibroma: Clinical Characteristics, Treatment, and Prognosis[J].WORLD NEUROSURGERY.2019,125:E843-E848.doi:10.1016/j.wneu.2019.01.197.
APA:
Wang, Ke,Ma, Xiu-Jian,Hao, Shu-Yu,Du, Jiang,Zhang, Li-Wei...&Wu, Zhen.(2019).Skull Base Juvenile Psammomatoid Ossifying Fibroma: Clinical Characteristics, Treatment, and Prognosis.WORLD NEUROSURGERY,125,
MLA:
Wang, Ke,et al."Skull Base Juvenile Psammomatoid Ossifying Fibroma: Clinical Characteristics, Treatment, and Prognosis".WORLD NEUROSURGERY 125.(2019):E843-E848